A San Diego-based biopharmaceutical company reported promising results Thursday from a clinical trial of COVID-19 treatment conducted in collaboration with Renmin Hospital in Wuhan, China. Ansun Biopharma said preliminary data showed that DAS181, a drug with antiviral properties, may have contributed to the reduction and elimination of COVID-19 symptoms in four patients suffering from severe […]
